Bevacizumab at first recurrence after standard radio-chemotherapy is associated with improved overall survival in glioblastoma patients with large tumor burden
对于接受标准放化疗后首次复发的胶质母细胞瘤患者,贝伐珠单抗治疗可改善肿瘤负荷较大的患者的总生存期。
期刊:Neuro-Oncology Practice
影响因子:2.5
doi:10.1093/nop/npy021
Nguyen, Huy Tram; Nguyen, Nhung; Liu, Liang Yen; Dovek, Laura; Lenchner, Daniel; Harris, Robert; Ozer, Byram; Ravelo, Arliene; Sommer, Nicolas; Sim, Myung Shin; Elashoff, Robert; Green, Richard; Nghiemphu, Phioanh Leia; Cloughesy, Timothy Francis; Ellingson, Benjamin; Lai, Albert